Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells

DNA methylation and BLC-2 are potential therapeutic targets in acute myeloid leukemia (AML). We investigated pharmacologic interaction between the DNA methyltransferase inhibitor 5-azacytidine (5-AZA) and the BCL-2 inhibitor ABT-737. Increased BCL-2 expression determined by reverse phase protein ana...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tsao, Twee, Shi, Yuexi, Kornblau, Steven, Lu, Hongbo, Konoplev, Sergej, Antony, Ansu, Ruvolo, Vivian, Qiu, Yi Hua, Zhang, Ninaxiang, Coombes, Kevin R., Andreeff, Michael, Kojima, Kensuke, Konopleva, Marina
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3750747/
https://ncbi.nlm.nih.gov/pubmed/22893484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-012-1537-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller